Ati cautat: evaluarea riscului de diabet
Protocol terapeutic: A10BJ06 – DCI SEMAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ02 DCI LIRAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10AE54 – DCI COMBINAŢII (INSULINE GLARGINE + LIXISENATIDUM) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AA26 – LUPUS ERITEMATOS SISTEMIC – AGENȚI BIOLOGICI: BELIMUMABUM**1 (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ05 – DCI DULAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC18 – DCI PEMBROLIZUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BD08 – DCI COMBINAȚII (VILDAGLIPTIN+METFORMIN) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M09AX03 – DCI ATALUREN (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: R03AL04 – DCI COMBINAŢII (INDACATEROLUM + GLICOPIRONIUM) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BX10 – DCI LIXISENATIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
